(Press-News.org) One of the beneficial gut bacteria residing in the human gut, which normally cannot survive in an environment with oxygen, can now be made oxygen-tolerant. This is a key finding in the development of future probiotic treatment that is now being explored to improve glucose control in individuals with prediabetes.
Our intestines are home to trillions of bacteria, the gut microbiota, which are important for functions such as digesting food and educating and activating the immune system. During the past decade it has been clarified that changes in the bacterial composition can be linked to various diseases.
Significant expectations have been attributed to the next generation probiotics, or live bacteria products, which can replace the missing bacteria in individuals with increased risk of developing diseases. However, a significant problem has been to overcome the bacteria’s oxygen sensitivity, since the vast majority are strictly anaerobic. With bacteria dying just seconds after being exposed to oxygen in the air, it has been hard to develop live bacterial cultures of extremely oxygen sensitive bacteria.
A naturally occurring symbiosis
In a paper published in the journal Nature, researchers from the University of Gothenburg and the probiotic company BioGaia AB, report how they have overcome the oxygen sensitivity of an anti-inflammatory gut bacterium, Faecalibacterium prausnitzii, which is significantly reduced in conditions including type 2 diabetes and cardiovascular disease.
In their study, Faecalibacterium prausnitzii was co-isolated with another bacterium, Desulfovibrio piger, which has beneficial effects on Faecalibacterium prausnitzii growth and function. By subsequently “training” the oxygen-sensitive bacteria in a favorable electrochemical environment, the researchers were able to isolate more oxygen-tolerant Faecalibacterium prausnitzii. The team’s leader, Professor Fredrik Bäckhed, explains:
“By combining a naturally occurring symbiosis with “training” of the bacteria, we have established a new strategy for producing otherwise oxygen-sensitive bacteria as live biotherapeutic products, which could prevent diseases when these bacteria are reduced in number.”
Studying the impact on sugar control
The first author of the study is Muhammad Tanweer Khan, a researcher in Professor Bäckhed’s team who previously discovered this symbiosis. He also represents the probiotic company BioGaia AB, which helped to develop the bacteria for the proposed dietary supplement.
“When these bacteria were grown together, both the biomass – in other words, the number of bacteria – and the production of butyrate – which has an anti-inflammatory effect – increased,” he says. “This will enable us to increase the production yield, and to potentially increase butyrate production in the future.”
The study shows that the combination of bacteria is safe for human consumption. The next step will be a study to investigate how supplementation with these bacteria may affect sugar control in individuals with prediabetes.
“We have high hopes,” concludes Professor Bäckhed. “Further studies will show if we are correct in our hypothesis that gut bacteria have the potential to improve our health.”
More information: Bäckhed Lab https://backhedlab.org/ and MetaboGen AB https://www.metabogen.se/, part of BioGaia AB https://www.biogaia.com/
END
Important step toward next-generation probiotics
2023-08-02
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Infertility may lead to more severe menopause symptoms
2023-08-02
CLEVELAND, Ohio (August 2, 2023)—Not all women experience menopause the same way. The severity of menopause symptoms is influenced by a multitude of behavioral, biological, social, psychological, and demographic factors. A new study suggests that infertility may also be a risk factor for some menopause symptoms, including depressive mood, irritability, and sleep problems. Results of the study are published online today in Menopause, the journal of The Menopause Society.
A woman’s reproductive history has been implicated as a factor in the timing of menopause onset and the prevalence of menopause ...
Unveiling the mechanism underlying orofacial movements during reward processing in animals
2023-08-02
In animals, movements such as locomotion or grooming are known to influence neuronal activity within the cerebral cortex. Moreover, recent studies also suggest that these changes in neuronal activity are not confined to a specific area but are pervasive throughout cortical and subcortical regions of the brain. Interestingly, in animals trained for reward-based learning tasks, such spontaneous movements—despite being uninstructed and unnecessary—may be aligned to task events and may significantly contribute to ...
How immunity contributes to ageing and neurodegeneration
2023-08-02
As we age, our bodies undergo various changes that can impact our overall health and make us more susceptible to diseases. One common factor in the ageing process is low-grade inflammation, which contributes to age-related decline and impairment. However, the precise pathways responsible for this inflammation and their impact on natural ageing have remained elusive until now.
A new study led by Andrea Ablasser at EPFL now shows that a molecular signaling pathway called cGAS/STING, plays a critical role in driving chronic inflammation and functional decline during aging. By blocking the STING protein, the researchers were able to suppress inflammatory responses in senescent ...
Cost of translating consent documents may serve as a barrier to participation of members of underrepresented groups in clinical trials
2023-08-02
Cancer research centers conducting clinical trials could enroll more patients from underrepresented racial and ethnic groups by placing greater emphasis on relieving investigators of the costs of translating consent documents into languages other than English, according to a UCLA Jonsson Comprehensive Cancer Center study.
“We identified a readily addressable weakness in the clinical trial process, and we believe that overcoming this barrier, as we have begun to do, will ensure better representation of trial participants from traditionally underrepresented racial and ethnic groups, ...
Nature’s kitchen – how a chemical reaction used by cooks helped create life on Earth
2023-08-02
Maillard reaction locks away 4 million tonnes of organic carbon a year
Process helped stabilise conditions for complex life to evolve
A chemical process used in the browning of food to give it its distinct smell and taste is probably happening deep in the oceans, where it helped create the conditions necessary for life.
Known as the Maillard reaction after the French scientist who discovered it, the process converts small molecules of organic carbon into bigger molecules known as polymers. In ...
Genetic variant linked to lower levels of HIV virus in people of African ancestry
2023-08-02
An international team of researchers has found a genetic variant that may explain why some people of African ancestry have naturally lower viral loads of HIV, reducing their risk of transmitting the virus and slowing progress of their own illness.
Reported today in Nature, this is the first new genetic variant related to HIV infection discovered in nearly 30 years of research. It could, in the future, help direct the development of new treatments approaches for those living with HIV.
HIV remains a major threat to global health. According to UNAIDS, there were 38.4 million people living with HIV globally in 2021. A combination of pre-exposure drugs and medicines that dramatically ...
An ancient grain unlocks genetic secrets for making bread wheat more resilient
2023-08-02
Building on the Middle East’s reputation as one of the historical birthplaces of cereal crop domestication, a KAUST-led team has compiled the first complete genome map of an ancient grain known as einkorn[1].
The 5.2-billion-letter-long sequence provides a window into the evolutionary origins of different wheat species. It could help farmers and crop breeders to develop bread wheat varieties with enhanced disease resistance, higher yields and improved hardiness.
“By understanding the genetic diversity and evolutionary history of einkorn, researchers can now leverage its potential for future ...
Perinatal depression screening among sexual minority women
2023-08-02
About The Study: The findings of this study suggest that, although sexual minority women are at high risk of postpartum depression, their sexual identities are largely undocumented in medical records, highlighting the need for strategies to measure sexual orientation that can reliably capture this information.
Authors: Leiszle Lapping-Carr, Ph.D., of the Northwestern University Feinberg School of Medicine in Chicago, is the corresponding author.
To access the embargoed study: Visit our For The Media website at ...
Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older adults
2023-08-02
About The Study: In this study of 6.3 million older U.S. adults, the mRNA-1273 (Moderna) vaccine was associated with a slightly lower risk of several adverse events compared with BNT162b2 (Pfizer-BioNTech), possibly due to greater protection against COVID-19. Future research should seek to formally disentangle differences in vaccine safety and effectiveness and consider the role of frailty in assessments of COVID-19 vaccine performance.
Authors: Daniel A. Harris, Ph.D., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding ...
Moderna is safest, most effective mRNA vaccine against COVID-19 for older adults, study shows
2023-08-02
PROVIDENCE, R.I. [Brown University] — While mRNA vaccines against COVID-19 have been found to be safe and effective for the general population, in-depth evidence about safety and effectiveness for older adults and individuals with chronic health conditions is more limited.
To address that gap, a team led by Brown University researchers conducted the largest head-to-head comparison study of the two mRNA vaccines approved by the U.S. Food and Drug Administration — the Moderna and Pfizer-BioNTech vaccines. The results, published in JAMA Network Open, ...